DCGI nod for Glenmark Pharma clinical trials on Favipiravir antiviral tablets for COVID-19 patients

150 subjects with mild to moderate COVID-19 will be randomised in the study in a 1:1 ratio to Favipiravir with standard supportive care or standalone standard supportive care.

from The Hindu - Business https://ift.tt/2yTG64T
via IFTTT